A5 completes CRO SOPs
A5 Laboratories has completed its CRO testing and analytical standard operating procedures (SOPs) ahead of schedule.
Completing the 3,000 pages of procedures for microbiological and chemical testing analysis, as well as related supporting documents, furthers A5’s goal of establishing its contract research unit.
The documents provide a blue print to guide A5’s scientific and regulatory procedures in support of its interferon-based products group and CRO clients.
"Completion of our SOP documentation is a significant milestone for the establishment of our world class CRO division. I am very pleased that our team was able to complete this task ahead of schedule", said Richard Azani, president and CEO of A5.
